REFERÊNCIAS

  1. Ciffo F.

    Determination of the Spectrum of Antibiotic Ressitance of the > Strains of Enterogermina.

    Chemioterapia. Val III-n 1- February 1984.

  2. Abbrescia A et al.

    Antibiotic Sensitivity of Bacillus clausii Strains in Commercial Preparation Clinical Immunology, Endocrine & Metabolic Drugs, 2014, Vol. 1, No. 2

  3. Mazza et al.

    The use, of Bacillus Subtilis in children treated with antibiotcs”

  4. Mazza G.

    Genetic studies on the transfer of antibiotic resistence genes in bacillus subtillis strains.

    Chemioterapia. Vol. II-n. 1 – February 1983

  5. Galopin et al.

    A chromosomal chioramphenicol acetyltranferase determinat from a probiotic strain of bacillus clausii.

    FEMS Microbiol Lett 296

  6. Bozdogan et al.

    Chromosomal aadD2 Encodes an Aminoglycoside Nucleotidytransferase in bacillus clausii.

    Antimicrobial agents and chemioterappy, Apr. 2003, p 1343-1346 2003

  7. Bozdogan et al.

    Characterization of a new erm-related macrolide resistance gene presente in probiotic strains of bacillus clausii.

    Applies Antimicrobial agents and chemiotherapy, Nov 2007, p. 4009-4014

  8. Girlich et al.

    Molecular and Biochemical Characterization of the Chromosome-Encoded Class A- Lactamase BCL-1 from Bacillus clausii

  9. Summary of Product Characteristics (SmPC) of Enterogermina

  10. IMS OTC Global Analyser

    “Enterogermina is No. 1 selling probiotic in values and volume”

    June 2017

  11. Sugar free Statement from Origgio

  12. Lactose free Statement from Origgio

  13. Preservatives free Statement from Origgio